News - Opening the way to the Future of Peptide and Oligonucleotide Pharmaceuticals through the Technology Development Leveraging Innovative Japanese Technologies

News

2022/11/29 Participated in Boulder Peptide Symposium held in Colorado, USA on Nov. 7-10, 2022
2022/11/12 Our Director will give a lecture at the Japanese Society for Process Chemistry 2022 Winter Symposium to be held on December 2.
2022/10/28 Announcement of Website Renewal
2022/09/08 CAGE Bio, TAGCyx and PeptiStar announce execution of a license and supply agreement for development and commercialization of TAGX-0003 for the treatment of immunodermatology diseases mediated by the IFN-γ pathway
2020/12/01 PeptiStar has issued New Shares through Third-Party Allotment and raised 1.79 billion Yen.
2020/08/31 PeptiStar Inc., Manufacturing Facilities
2020/08/27 We will exhibit & make a presentation at US TIDES (virtual event)
2020/04/22 NeuroScientific Biopharmaceuticals(NSB) announced NSB signed on manufacturing service agreement.
2019/12/06 AMED and PeptiStar announced they accomplished the CiCLE project goal, “establishment of a global leading contract manufacturing organization (CMO) for constrained peptide medicines”.
2019/12/03 We will exhibit & make a presentation at Asia Tides
2019/10/25 We will exhibit at CPhI Worldwide 2019
2019/08/30 PeptiStar website was updated
2019/07/10 PeptiStar held a completion ceremony of its headquarter plant
2019/06/11 Appointment of New President & CEO
2019/05/07 Construction Complete : HQ R&D Building